haematology
Blood cancers

Is 65 the new 55 when it comes to transplant eligibility in multiple myeloma?

Sponsored by Janssen Cilag Pty Ltd

More patients than ever could be eligible for transplant Traditionally, an arbitrary measure – age – has been the marker of a patient’s eligibility for autologous stem cell transplantation (ASCT).1 Which side of the golden age of 65 a patient was determined their treatment choice – to transplant – or not to transplant. These days, ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic